Raptor Pharmaceuticals (RPTP +4.4%) pokes out a tidy gain after the firm announces that it signed a R&D agreement with the National Institutes of Diabetes and Digestive and Lidney Diseases to conduct a Phase 2b clinical trial in Q1 on the efficacy of its RP104 tablet.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Benzinga.com (Feb 23, 2015)
at Investor's Business Daily (Jan 6, 2015)
at Investor's Business Daily (Jan 5, 2015)
at Nasdaq.com (Dec 29, 2014)
at CNBC.com (Mar 13, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs